REGENXBIO (RGNX) Stock: Buy, Sell, or Hold?
$8.15
-0.32 (-3.78%)
▼
5d:
+10.43%
30d:
+18.46%
90d:
-24.29%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (21%)
Quality Score
32/100
Position
EXTENDED
30-Day Fair Range
$6.95 – $7.86
Position: EXTENDED
Forward P/E & Valuation
-2.8x
Next 12M consensus est.
Wall Street Target
$24.00
+183.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$7.00 / $8.88
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: RGNX shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When RGNX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: RGNX is currently trading at $8.15, which is considered extended relative to its 30-day fair value range of $6.95 to $7.86.
Technical Outlook: Technically, RGNX is in a strong downtrend. Immediate support is located at $7.00, while resistance sits at $8.88. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: RGNX scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $24.00 (+183.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RGNX is in a strong downtrend. Immediate support is located at $7.00, while resistance sits at $8.88. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: RGNX scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $24.00 (+183.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$6.95 -
$7.86
Company Quality Score
32/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
Trading Range & Key Levels
30-Day Trading Range
$6.95 -
$7.86
Current vs Trading Range
EXTENDED
Support Level
$7.00
Resistance Level
$8.88
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.8%)
- BULLISH: Trading 183.4% below Wall St target ($24.00)
- WARNING: Composite score 32/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-2.82
Wall Street Target
$24.00
(+183.4%)
Revenue Growth (YoY)
-69.2%
Profit Margin
-113.9%
Share RGNX Analysis
Share this live RGNX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (RGNX)
Bearish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 5, 2026
Daily AI digest
AI Retail Discussion Summary:
Bearish sentiment on $RGNX is growing as the company's expenses outpace revenues according to a StockTwits user.
Key Retail Themes:
Financials
Company Performance
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 1:52 PM ET
Data refreshes hourly during market hours. Next update: 2:52 PM
Data refreshes hourly during market hours. Next update: 2:52 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RGNX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 37 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 31 SELL |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 41 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
18 analysts |
$139 | 41 HOLD |
|
SYRE
Spyre Therapeutics Inc. |
STRONG BUY
18 analysts |
$122 | 44 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive RGNX Research Pages
